Artal Group’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,011,500	Closed	-$8.11M	–	45
2024 Q2	$8.11M	Buy	+1,011,500	New	+$8.11M	0.21%	45
2021 Q2	–	Sell	-400,000	Closed	-$12.7M	–	153
2021 Q1	$12.7M	Hold	400,000	–	–	0.22%	77
2020 Q4	$18.6M	Hold	400,000	–	–	0.4%	55
2020 Q3	$13.2M	Sell	400,000 -100,000	-20%	-$3.29M	0.32%	58
2020 Q2	$13.7M	Sell	500,000 -250,000	-33%	-$6.86M	0.38%	47
2020 Q1	$22.5M	Buy	750,000 +250,000	+50%	+$7.48M	0.95%	23
2019 Q4	$13.8M	Sell	500,000 -200,000	-29%	-$5.54M	0.53%	31
2019 Q3	$12.7M	Hold	700,000	–	–	0.51%	33
2019 Q2	$17.2M	Buy	700,000 +200,000	+40%	+$4.9M	0.69%	26
2019 Q1	$4.76M	Hold	500,000	–	–	0.19%	63
2018 Q4	$4.43M	Sell	500,000 -200,000	-29%	-$1.77M	0.16%	48
2018 Q3	$7.88M	Hold	700,000	–	–	0.2%	40
2018 Q2	$8.96M	Buy	700,000 +240,000	+52%	+$3.07M	0.19%	34
2018 Q1	$7.77M	Buy	+460,000	New	+$7.77M	0.1%	33